)
)
Molecular Residual Disease Monitoring in Breast Cancer
- Approaches for ctDNA analysis in early breast cancer
- Clinical utility of ctDNA monitoring to predict relapse
- Current landscape of ctDNA analysis for relapse monitoring
- Are we there yet, what do we need for ctDNA monitoring to become a tool with clinical utility
